Subclinical Progressive Course of Orbital Cholesteatoma. Clinical Case
https://doi.org/10.18008/1816-5095-2026-2-402-408
Abstract
A clinical case of subclinical orbital cholesteatoma is presented, where disease progression was diagnosed using dynamic magnetic resonance imaging (MRI) over 14 years. Considering the localization of the lesion, a transcutaneous subperiosteal exploratory orbitotomy was performed, involving the complete removal of tumor masses followed by histopathological and immunohistochemical examination of the surgical material. The importance of assessing the tumor’s histopathological characteristics lies in the need for differential diagnosis between cholesteatoma and cholesterol granuloma of the orbit, which significantly impacts prognosis and followup strategies. Given the risk of recurrence, the patient in this case was informed about the necessity of regular check-ups and orbital computed tomography (CT) for monitoring.
About the Authors
I. E. PanovaRussian Federation
Panova Irina E. - MD, Professor, deputy director for Scientific work
Yaroslav Gashek str., 21, Saint Petersburg, 192283;
Kirochnaya str., 41, Saint Petersburg, 191015;
Universitetskaya Emb., 7–9, Saint Petersburg, 199034
M. V. Melikhova
Russian Federation
Melikhova Mariia V. - PhD, head оf the Oculoplastics, Ophthalmooncology, and Radiotherapy Department, ophthalmologist
Yaroslav Gashek str., 21, Saint Petersburg, 192283
E. M. Svistunova
Russian Federation
Svistunova Evgeniya M. - ophthalmologist
Yaroslav Gashek str., 21, Saint Petersburg, 192283
S. L. Vorobyev
Russian Federation
Vorobyev Sergey L. - PhD, director of “National Center for Clinical Morphological Diagnostics”, pathologist
Slavy Ave., 32A, Saint Petersburg, 192071
References
1. Cruveilhier J. Anatomic pathologique du corps humain. 1st Edition. Paris: J. B. Baillibre; 1829.
2. Jordan DR, Spitellie P, Brownstein S, Rawlings N, Gilberg SM. Orbital cholesterol granuloma and cholesteatoma: significance of differentiating the two. Ophthalmic Plastic & Reconstructive Surgery. 2007;23(5):415–417. doi: 10.1097/iop.0b013e318137a6fe.
3. Ugga L, Stilo S, Napolitano P, Guadagno E, Iuliano A, Del Basso de Caro ML, Elefante A. Orbitofrontal cholesterol granuloma: case report and review of the literature. Quantitative Imaging in Medicine and Surgery. 2017;7(3):373–377. doi: 10.21037/qims.2017.04.04.
4. Yan J, Cai Y, Liu R, Lin J, Li J. Cholesterol Granuloma of the Orbit. The Journal of Craniofacial Surgery. 2015;26(2):124–126. doi: 10.1097/scs.0000000000001347.
5. De Conciliis C. Epidemiology of orbital disease. Ophthalmology. 2003;110(7):1288. doi: 10.1016/s0161-6420(03)00706-1.
6. Saakyan S. Clinical Oncology of Visual Organ. Effective pharmacotherapy. 2015; 30:20–27 (In Russ.).
7. Sarvarov D, Israfilova G, Babushkin А. Rare case of orbital cholesteatoma, which has led to cicatricial deformation of upper eyelid. Point of view. East-West. 2016;2:176–179 (In Russ.).
8. Rizvi SA, Hasan M, Alam MS. Cholesterol granuloma of the orbit: an atypical presentation. Indian Journal of Ophthalmolmology. 2014;62(3):344–346. doi: 10.4103/0301-4738.111187.
9. Hughes JD, Jacob JT, Garrity JA, Salomao DR, Link MJ. Orbitofrontal Cholesterol Granuloma: Four Case Reports and a Systematic Review of the English Literature. World Neurosurgery. 2016;87:355–361.doi: 10.1016/j.wneu.2015.11.095.
10. Аnikin MI, Kanafyev DM, Аnikin IA, Bokuchava TA. The middle ear cholesteatoma: defnition, classifcation and etiopathogenesis issues (brief literature review). Part I. Russian Otorhinolaryngology. 2016;3(82):115–124 (In Russ.). doi: 10.18692/1810-4800-2016-3-115-124.
11. Barkhash SA, Trinchuk VV. Tumors of the eye, its adnexa, and orbit. In: Tumors of the eye, its adnexa, and orbit. Ed. by NA Puchkovskaya. Kyiv: Zdorovya; 1978:216– 227 (In Russ.).
12. Brovkina AF. Orbital diseases: a manual for physicians. 2nd edition, revised and enlarged. Moscow: Medical Information Agency; 2008:256 (In Russ.).
13. Guadarrama-Ortiz P, Choreño-Parra JA, Pacheco-Sánchez FJ, Rodríguez-Nava AI, García-Quintero G, Rodríguez-Muñoz PE, Sánchez-Garibay C, ÁngelesCastellanos M. The pterional approach for the surgical resection of an orbital cholesteatoma: a case report. Journal of Medical Case Reports. 2021;15(1):18. doi: 10.1186/s13256-020-02579-3.
14. Tejani N, Kshirsagar R, Song B, Liang J. Evolving Treatment of Frontal Sinus Cholesteatoma: A Case Report. The Permanente Journal. 2020;24:19.048. doi: 10.7812/TPP/19.048.
15. Selleck AM, Desai D, Thorp BD, Ebert CS, Zanation AM. Management of frontal sinus tumors. Otolaryngologic Clinics of North America. 2016;49(4):1051–1065. doi: 10.1016/j.otc.2016.03.026.
16. Gonçalves DCG, Santos TS, Silva VCM, Costa HNAA Carvalho CMF. Frontal Sinus Cholesteatoma Presenting with Intracranial and Orbital Complications: Diagnosis and Treatment. Turkish Archives of Otorhinolaryngology. 2022;60(4):234–237. doi: 10.4274/tao.2022.2022-7-7.
17. Zoia C, Pusateria A, Carena P, Matti E, Galioto S, Benazzo M, Gaetani P, Pagella F. Frontal sinus cholesteatoma with intracranial complication. ANZ Journal of Surgery. 2018;88(1–2):110–112. doi: 10.1111/ans.13218.
18. Hansen S, Sorensen CH, Stage J, Mouritzen A, Cayé-Thomasen P. Massive cholesteatoma of the frontal sinus: Case report and review of the literature. Auris Nasus Larynx. 2007;34(3):387–392. doi: 10.1016/j.anl.2006.11.011.
19. Kim TG, Whangbo CH, Yoo JH, Park HJ, Geum SY, Shin SH, Ye MK. Squamous cell carcinoma arising from a cholesteatoma of the maxillary sinus: a case report. Brazilian Journal of Otorhinolaryngology. 2024;90(3):101408. doi: 10.1016/j.bjorl.2024.101408.
20. Rothschild S, Ciernik IF, Hartmann M, Schuknecht B, Lütolf UM, Huber AM. Cholesteatoma triggering squamous cell carcinoma: case report and literature review of a rare tumor. American Journal of Otolaryngology. 2009;30(4):256–260. doi: 10.1016/j.amjoto.2008.06.011.
Review
For citations:
Panova I.E., Melikhova M.V., Svistunova E.M., Vorobyev S.L. Subclinical Progressive Course of Orbital Cholesteatoma. Clinical Case. Ophthalmology in Russia. 2026;23(2):402-408. (In Russ.) https://doi.org/10.18008/1816-5095-2026-2-402-408
JATS XML




































